What is the optimal strategy to confirm the diagnosis of epithelial ovarian carcinoma (EOC) prior to neoadjuvant chemotherapy (NAC)? Article

Dodge, JE, Mackay, H, Klachook, S et al. (2009). What is the optimal strategy to confirm the diagnosis of epithelial ovarian carcinoma (EOC) prior to neoadjuvant chemotherapy (NAC)? . JOURNAL OF CLINICAL ONCOLOGY, 27(15_suppl), 5511-5511. 10.1200/jco.2009.27.15_suppl.5511

cited authors

  • Dodge, JE; Mackay, H; Klachook, S; Bernardini, M; Shaw, P; Murphy, KJ; Lo, E; Rosen, BP; Freedman, O

authors

publication date

  • May 20, 2009

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 3215 Reproductive Medicine
  • 4.1 Discovery and preclinical testing of markers and technologies
  • Cancer
  • Clinical Research
  • Ovarian Cancer
  • Rare Diseases
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 5511

end page

  • 5511

volume

  • 27

issue

  • 15_suppl